Market Overview:
The global infectious enteritis treatment market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of infectious enteritis, rising demand for antibiotics and other drugs, and growing awareness about available treatments.
The global infectious enteritis treatment market is segmented by type into antibiotics, ampicillin, chloramphenicol, and other drugs. The antibiotics segment is expected to grow at a CAGR of 6% from 2018 to 2030 due to the increasing incidence of infections and rising demand for effective treatments.
Product Definition:
Infectious enteritis is a condition that results when the small intestine becomes inflamed due to a viral, bacterial, or parasitic infection. Symptoms may include diarrhea, nausea, vomiting, abdominal pain and cramps, and fever. Treatment depends on the cause of the infection and may include antibiotics for bacterial infections or antiviral medication for viral infections.
Antibiotics:
Antibiotics Market is expected to grow at a lucrative rate during the forecast period owing to rise in prevalence of infectious diseases coupled with increasing geriatric population base. Increasing incidences of infectious diseases such as typhoid, cholera, food poisoning and hepatitis are anticipated to drive the growth over the next seven years. According to CDC (Centers for Disease Control and Prevention), every year around 2 million people get infected with Salmonella typhi bacteria which causes gastroenteritis.
Ampicillin:
Ampicillin is a penicillin antibiotic and is categorized as semi-synthetic. It's Spectrum of Action ranges from the upper respiratory tract to the lower urinary tract. Ampicillin can be used in treating infections due to its ability to inhibit protein synthesis by binding to the ribosome, thus causing cell death.
Application Insights:
Based on application, the market is segmented into hospital pharmacy, online pharmacy, pharmacy and others. Hospital pharmacies are expected to dominate the market throughout the forecast period owing to a high prevalence of infectious diseases coupled with a rising number of hospital admissions. According to WHO, in 2016 about 1 out of 5 patients in developing countries were admitted to an outpatient department or a primary care facility within 1 month of diagnosis. Thus increasing demand for effective antimicrobial drugs will boost product demand over the forecast period.
The online pharmacies are expected register significant growth during the study period owing to factors such as availability of wide range products at lower prices and convenience among other advantages associated with it which is likely fuel their revenue growth over next seven years.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to increasing prevalence of infectious enteritis and rising awareness about available treatment options. In addition, presence of key players in this region will also help boost growth. For instance, FrieslandCampina has a wide distribution network across North America which helps it reach out to more customers at a lower cost as compared to other companies operating in the same segment.
Asia Pacific is estimated to be fastest growing regional market during the forecast period owing with rapid economic development coupled with increase in per capita income and rise in consumer disposable income levels which enable people buy antibiotics over-the-counter (OTC).
Growth Factors:
- Increasing incidence of infectious enteritis
- Rising awareness about infectious enteritis and its treatment options
- Growing demand for effective and affordable treatments for infectious enteritis
- Technological advancements in the field of infectious enteritis treatment
- increasing funding for research and development activities in the field of infectious enteritis treatment
Scope Of The Report
Report Attributes
Report Details
Report Title
Infectious Enteritis Treatment Market Research Report
By Type
Antibiotics, Ampicillin, Chloramphenicol, Other
By Application
Hospital Pharmacy, Online Pharmacy, Pharmacy, Other
By Companies
Abbott Laboratories, Baxter International, Pfizer, Bristol-Myers Squibb, Actelion Pharmaceuticals, Merck & Company, Lonza, BioGaia, ZBiotics, Evolve Biosystems
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
250
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Infectious Enteritis Treatment Market Report Segments:
The global Infectious Enteritis Treatment market is segmented on the basis of:
Types
Antibiotics, Ampicillin, Chloramphenicol, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacy, Online Pharmacy, Pharmacy, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- Baxter International
- Pfizer
- Bristol-Myers Squibb
- Actelion Pharmaceuticals
- Merck & Company
- Lonza
- BioGaia
- ZBiotics
- Evolve Biosystems
Highlights of The Infectious Enteritis Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Antibiotics
- Ampicillin
- Chloramphenicol
- Other
- By Application:
- Hospital Pharmacy
- Online Pharmacy
- Pharmacy
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Infectious Enteritis Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
There is no one-size-fits-all answer to this question, as the best treatment for infectious enteritis will vary depending on the individual's specific symptoms and health condition. However, some common treatments for infectious enteritis include antibiotics and dietary changes.
Some of the key players operating in the infectious enteritis treatment market are Abbott Laboratories, Baxter International, Pfizer, Bristol-Myers Squibb, Actelion Pharmaceuticals, Merck & Company, Lonza, BioGaia, ZBiotics, Evolve Biosystems.
The infectious enteritis treatment market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Infectious Enteritis Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Infectious Enteritis Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Infectious Enteritis Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Infectious Enteritis Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Infectious Enteritis Treatment Market Size & Forecast, 2018-2028
4.5.1 Infectious Enteritis Treatment Market Size and Y-o-Y Growth
4.5.2 Infectious Enteritis Treatment Market Absolute $ Opportunity
Chapter 5 Global Infectious Enteritis Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Infectious Enteritis Treatment Market Size Forecast by Type
5.2.1 Antibiotics
5.2.2 Ampicillin
5.2.3 Chloramphenicol
5.2.4 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Infectious Enteritis Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Infectious Enteritis Treatment Market Size Forecast by Applications
6.2.1 Hospital Pharmacy
6.2.2 Online Pharmacy
6.2.3 Pharmacy
6.2.4 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Infectious Enteritis Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Infectious Enteritis Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Infectious Enteritis Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Infectious Enteritis Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Infectious Enteritis Treatment Market Size Forecast by Type
9.6.1 Antibiotics
9.6.2 Ampicillin
9.6.3 Chloramphenicol
9.6.4 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Infectious Enteritis Treatment Market Size Forecast by Applications
9.10.1 Hospital Pharmacy
9.10.2 Online Pharmacy
9.10.3 Pharmacy
9.10.4 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Infectious Enteritis Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Infectious Enteritis Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Infectious Enteritis Treatment Market Size Forecast by Type
10.6.1 Antibiotics
10.6.2 Ampicillin
10.6.3 Chloramphenicol
10.6.4 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Infectious Enteritis Treatment Market Size Forecast by Applications
10.10.1 Hospital Pharmacy
10.10.2 Online Pharmacy
10.10.3 Pharmacy
10.10.4 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Infectious Enteritis Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Infectious Enteritis Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Infectious Enteritis Treatment Market Size Forecast by Type
11.6.1 Antibiotics
11.6.2 Ampicillin
11.6.3 Chloramphenicol
11.6.4 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Infectious Enteritis Treatment Market Size Forecast by Applications
11.10.1 Hospital Pharmacy
11.10.2 Online Pharmacy
11.10.3 Pharmacy
11.10.4 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Infectious Enteritis Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Infectious Enteritis Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Infectious Enteritis Treatment Market Size Forecast by Type
12.6.1 Antibiotics
12.6.2 Ampicillin
12.6.3 Chloramphenicol
12.6.4 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Infectious Enteritis Treatment Market Size Forecast by Applications
12.10.1 Hospital Pharmacy
12.10.2 Online Pharmacy
12.10.3 Pharmacy
12.10.4 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Infectious Enteritis Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Infectious Enteritis Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Infectious Enteritis Treatment Market Size Forecast by Type
13.6.1 Antibiotics
13.6.2 Ampicillin
13.6.3 Chloramphenicol
13.6.4 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Infectious Enteritis Treatment Market Size Forecast by Applications
13.10.1 Hospital Pharmacy
13.10.2 Online Pharmacy
13.10.3 Pharmacy
13.10.4 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Infectious Enteritis Treatment Market: Competitive Dashboard
14.2 Global Infectious Enteritis Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott Laboratories
14.3.2 Baxter International
14.3.3 Pfizer
14.3.4 Bristol-Myers Squibb
14.3.5 Actelion Pharmaceuticals
14.3.6 Merck & Company
14.3.7 Lonza
14.3.8 BioGaia
14.3.9 ZBiotics
14.3.10 Evolve Biosystems
